Disseminated breast cancer cells prior to and after high-dose therapy (vol 10, pg 687, 2001)

被引：0
|
作者：
Krüger, WH
Kröger, N
Tögel, F
Renges, H
Badbaran, A
Hornung, R
Jung, R
Gutensohn, K
Gieseking, F
Jänicke, F
Zander, AR
机构：
来源：
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH | 2001年 / 10卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：919 / 919
页数：1
相关论文
共 50 条
  • [31] Implications for improved high-dose methotrexate therapeutic effects in cultured human breast cancer and bone marrow cells (vol 24, pg 452, 2000)
    Bowen, D
    CANCER DETECTION AND PREVENTION, 2001, 25 (02): : 222 - 222
  • [32] Persistence of isolated tumor cells in patients with breast cancer after sequential high-dose therapy with peripheral blood stem cell transplantation (PBSC).
    Hohaus, S
    Funk, L
    Brehm, M
    Abdallah, A
    Murea, S
    Kaul, S
    Haas, R
    BLOOD, 1996, 88 (10) : 501 - 501
  • [33] The presence of micrometastases before and after high-dose therapy in high-risk Stage II breast cancer patients.
    Kvalheim, G
    Erikstein, B
    Holte, H
    Hervik, I
    Gilen, E
    Sommer, H
    Anker, G
    Telhaug, R
    Kolstad, A
    Nesland, J
    BONE MARROW TRANSPLANTATION, 1999, 23 : S148 - S148
  • [34] Radiation therapy after high-dose chemotherapy with peripheral blood stem cell support for high-risk breast cancer
    Moreno, M
    Azinovic, I
    López-Picazo, JM
    Aramendía, JM
    Martínez-Monge, R
    Beltrán, C
    Aristu, JJ
    Rebollo, J
    Algarra, SM
    Fernández, O
    Brugarolas, A
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (04): : 347 - 353
  • [35] High-Dose Salvage Radiation Therapy for Prostate Cancer After Relapse Reply
    D'Angelillo, Rolando M.
    Ramella, Sara
    Trodella, Lucio
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 91 (03): : 682 - 682
  • [36] Salvage treatment for germ cell cancer after failed high-dose therapy
    Shamash, J
    Asterling, S
    Oliver, RTD
    ANNALS OF ONCOLOGY, 1998, 9 (07) : 787 - 788
  • [37] Disseminated tumor cells predict survival after neoadjuvant therapy in primary breast cancer
    Hall, Carolyn
    Krishnamurthy, Savitri
    Lodhi, Ashutosh
    Bhattacharyya, Anirban
    Anderson, Amber
    Kuerer, Henry
    Bedrosian, Isabelle
    Singh, Balraj
    Lucci, Anthony
    CANCER, 2012, 118 (02) : 342 - 348
  • [38] Four-cycle high-dose therapy with hematopoietic support for metastatic breast cancer: No improvement in outcomes compared with single-course high-dose therapy
    Hu, WW
    Negrin, RS
    Stockerl-Goldstein, K
    Johnston, LJ
    Shizuru, JA
    Wong, RM
    Chao, NJ
    Long, GD
    Feiner, RH
    Blume, KG
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2000, 6 (01) : 58 - 69
  • [39] INFLUENCE OF HIGH-DOSE MEDROXYPROGESTERONEACETATE THERAPY ON THE COAGULATION SYSTEM IN METASTATIC BREAST-CANCER
    SCHENK, H
    FEREBERGER, W
    BLUT, 1982, 45 (03): : 200 - 200
  • [40] HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN BREAST-CANCER RESISTANT TO ENDOCRINE AND CYTOTOXIC THERAPY
    DELENA, M
    BRAMBILLA, C
    VALAGUSSA, P
    BONADONNA, G
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1979, 2 (03) : 175 - 180
12345